natgillin/translations-raw huggingface dataset:
There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system. 
Renovaskularna hipertenzija Pri bolnikih z obojestransko stenozo ledvične arterije ali s stenozo arterije ene same delujoče ledvice,
EU/1/09/576/025 50 x 1 tablet (unit dose) EU/1/09/576/026 56 x 1 tablet (unit dose) EU/1/09/576/041 28 tablets (calendar pack) 
EU/1/09/576/025 50 x 1 tablet (enkratno odmerjanje) EU/1/09/576/026 56 x 1 tablet (enkratno odmerjanje) EU/1/09/576/041 28 tablet (koledarsko pakiranje)
Irbesartan 300 mg film-coated tablets are white to off white capsule shaped, film coated tablet. 
Izgled zdravila Irbesartan Teva in vsebina pakiranja Irbesartan Teva 300 mg filmsko obložene tablete: bele do belkaste filmsko obložene tablete v obliki kapsule.
EU/1/09/576/038 50 x 1 tablet (unit dose) EU/1/09/576/039 56 x 1 tablet (unit dose) EU/1/09/576/042 28 tablets (calendar pack) 
EU/1/09/576/038 50 x 1 tablet (enkratno odmerjanje) EU/1/09/576/039 56 x 1 tablet (enkratno odmerjanje) EU/1/09/576/042 28 tablet (koledarsko pakiranje)
Package leaflet: information for the user Irbesartan Teva 150 mg Film-Coated Tablets 
PODATKI V BRAILLOVI PISAVI Irbesartan Teva 150 mg filmsko obložene tablete
Package leaflet: information for the user Irbesartan Teva 300 mg Film-Coated Tablets 
PODATKI V BRAILLOVI PISAVI Irbesartan Teva 300 mg filmsko obložene tablete
For N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) the MAH must introduce the following specifications for the drug substance: 
Imetnik dovoljenja za promet z zdravilom mora za N-nitrozodimetilamin (NDMA)
Therefore, the use of irbesartan is not recommended. 
V zgodnjem obdobju nosečnosti uporaba zdravila Irbesartan Teva ni priporočljiva.
Povidone 
Preiskave
Respiratory, thoracic and mediastinal disorders Uncommon: cough 
Bolezni dihal, prsnega koša in mediastinalnega prostora Občasni:
In patients with high blood pressure and type 2 diabetes, 300 mg once daily is the preferred maintenance dose for the treatment of associated kidney disease. 
Pri bolnikih z visokim krvnim tlakom in sladkorno boleznijo tipa 2 zdravilo Irbesartan Teva upočasni pešanje delovanja ledvic.
Package leaflet: information for the user Irbesartan Teva 75 mg Film-Coated Tablets 
PODATKI V BRAILLOVI PISAVI Irbesartan Teva 75 mg filmsko obložene tablete
Because no information is available regarding the use of irbersartan during breast-feeding, irbesartan is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant. 
Priporočajo se alternativni načini zdravljenja s potrjeno varnostjo pri doječih materah, še zlasti pri dojenju novorojenčkov ali nedonošenčkov.
EU/1/09/576/012 50 x 1 tablet (unit dose) EU/1/09/576/013 56 x 1 tablet (unit dose) EU/1/09/576/040 28 tablets (calendar pack) 
EU/1/09/576/012 50 x 1 tablet (enkratno odmerjanje) EU/1/09/576/013 56 x 1 tablet (enkratno odmerjanje)
Common (may affect up to 1in 10 people): dizziness, feeling sick/vomiting, fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme). 
Krvne preiskave lahko pokažejo zvišanje vrednosti encima, ki kaže na delovanje mišic in srca (encim kreatin-kinaza).
hyperkalaemia Nervous system disorders Common: 
Bolezni živčevja Pogosti:
Your doctor will advise you. 
Zdravnik vam bo svetoval.
The dose is 0.5 ml. 
Odmerek je 0,5 ml.
Adolescents and adults 
Mladostniki in odrasli
After the Commission decision the Member State competent authorities, in liaison with the reference Member State, will update the product information as required. 
Po odločbi komisije bodo pristojni organi držav članic v povezavi z referenčno državo članico posodobili informacije o zdravilu, kot bo potrebno.
In controlled clinical studies, signs and symptoms were actively monitored during a 42-day follow-up period. 
V nadzorovanih kliničnih študijah so znake in simptome aktivno spremljali med 42-dnevnim opazovalnim obdobjem.
Because these adverse reactions were reported spontaneously, it is not possible to reliably estimate their frequency. 
Ker so o teh dogodkih poročali spontano, njihove pogostnosti ni mogoče zanesljivo oceniti.
Your doctor will advise if additional doses of vaccine are needed. 
Vaš zdravnik vam bo svetoval, ali so potrebni dodatni odmerki cepiva.
A second dose should be given according to official recommendations. 
Drugi odmerek je treba dati v skladu z uradnimi priporočili.
Inject the entire content of the vial. 
Injicirajte celotno vsebino viale.
The vaccinees were also requested to report any clinical events during the study period. 
Cepljene osebe so tudi prosili, da med obdobjem študije poročajo o vsakem kliničnem dogodku.
• loss of appetite 
• izguba apetita;
Dispose of in accordance with local regulations 
Odstranite v skladu z lokalnimi predpisi.
Immediate measures depend on the severity of the reaction (see section 4.4). 
Takojšnje ukrepanje je odvisno od resnosti reakcije (glejte poglavje 4.4).
The appropriate time and number of injections that will be given to you or your child will be determined by your doctor on the basis of appropriate official recommendations. 
Odločitev o primernem času in številu odmerkov, ki jih boste vi ali vaš otrok prejeli, bo sprejel zdravnik na podlagi ustreznih uradnih priporočil.
You or your child should be closely monitored as the responses to the vaccines may not be sufficient to ensure a protection against the illness (see section 2). 
Potreben bo skrbni nadzor vas ali vašega otroka, saj odziv na cepiva morda ne bo zadosten, da bi bila zagotovljena zaščita proti boleznim (glejte poglavje 2).
Children vaccinated in their first year of life may not be fully protected. 
Otroci, cepljeni v prvem letu življenja, morda ne bodo popolnoma zaščiteni.
The vaccine contains 9 mg of sorbitol, see section 4.4. 
Cepivo vsebuje 9 mg sorbitola, glejte poglavje 4.4.
There are no data to support the use of PRIORIX with any other vaccines. 
Ni podatkov, ki bi podpirali uporabo cepiva PRIORIX s kakšnimi drugimi cepivi.
Limited protection against measles may be obtained by vaccination up to 72 hours after exposure to natural measles. 
Omejena zaščita proti ošpicam je lahko dosežena s cepljenjem do 72 ur po izpostavljenosti naravnim ošpicam.
Tell your doctor if you or your child is taking, has recently taken or might take any other medicines (or other vaccines). 
Obvestite svojega zdravnika, če vi ali vaš otrok jemljete, ste pred kratkim jemali ali boste morda začeli jemati katerokoli drugo zdravilo (ali drugo cepivo).
However, some field studies report that the effectiveness against mumps may be lower than the observed seroconversion rates to mumps. 
Toda nekatere terenske študije navajajo, da je učinkovitost proti mumpsu morda manjša, kot je zabeleženi delež serokonverzije za mumps.
Under no circumstances should the interval between doses be less than four weeks (see sections 4.4 and 5.1). 
Nikakor pa presledek med odmerkoma ne sme biti krajši od štirih tednov (glejte poglavji 4.4 in 5.1).
What Priorix is and what it is used for 
Kaj je cepivo Priorix in za kaj ga uporabljamo
Arthralgia, arthritis 
Artralgija, artritis
Pharmaco-therapeutic group: Viral vaccine, ATC code J07BD52 
Farmakoterapevtska skupina: Virusna cepiva, oznaka ATC: J07BD52
A history of contact dermatitis to neomycin is not a contraindication. 
Kontaktni dermatitis na neomicin v anamnezi ni kontraindikacija.
Priorix contains sorbitol. 
Cepivo Priorix vsebuje sorbitol.
Patients with rare hereditary problems of fructose intolerance should not be vaccinated with PRIORIX since it contains sorbitol. 
Bolniki z redko dedno intoleranco na fruktozo ne smejo biti cepljeni s cepivom PRIORIX, ker vsebuje sorbitol.
If this is not possible, it must be stored in the refrigerator (2C - 8C) and used within 8 hours of reconstitution. 
Če to ni možno, ga shranite v hladilniku (2 ºC do 8 ºC) in uporabite v 8 urah po rekonstituciji.
For hypersensitivity reactions to egg proteins, see section 4.4. 
Za preobčutljivostne reakcije na jajčne proteine, glejte poglavje 4.4.
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 or neomycin. 
Preobčutljivost na zdravilne učinkovine ali katerokoli pomožno snov, navedeno v poglavju 6.1 ali na neomicin.
• if you or your child is allergic against any of the components of this vaccine (listed in section 6). 
• če ste vi ali vaš otrok alergični na katerokoli sestavino tega cepiva (navedeno v poglavju 6).
EXP: After reconstitution, use promptly or within 8 hours if stored in a refrigerator 
EXP: Cepivo je treba uporabiti takoj po rekonstituciji ali v 8 urah, če je shranjeno v hladilniku.
An evaluation of pharmacokinetics in vaccines is not necessary. 
Vrednotenje farmakokinetičnih lastnosti za cepiva ni zahtevano.
Although there are no data available concerning the protective efficacy of PRIORIX, immunogenicity is accepted as an indication of protective efficacy. 
Podatkov o zaščitni učinkovitosti cepiva PRIORIX sicer ni, vendar imunogenost velja za kazalnik zaščitne učinkovitosti.
Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue; 
Znaki alergijske reakcije lahko vključujejo srbeč kožni izpuščaj, težave z dihanjem in oteklino obraza ali jezika;
Only in the event the child is confirmed or suspected to be immunodeficient, risks and benefits of vaccinating the mother should be evaluated (see section 4.3). 
Samo v primeru, da ima otrok ugotovljeno imunsko pomanjkljivost ali da obstaja sum nanjo, je treba pretehtati koristi in tveganja cepljenja matere (glejte poglavje 4.3).
In case an epidemiological situation requires vaccinating infants in their first year of life (e.g. outbreak or travel to endemic regions), a second dose of PRIORIX should be given in the second year of life, preferably within three months after the first dose. 
Če epidemiološke okoliščine zahtevajo cepljenje dojenčkov v prvem letu življenja (npr. zaradi izbruha bolezni ali potovanja v endemska območja), mora otrok dobiti drugi odmerek cepiva PRIORIX v drugem letu življenja, po možnosti v treh mesecih po prvem odmerku.
Infants in their first year of life may not respond sufficiently to the components of the vaccines. 
Pri dojenčkih v prvem letu življenja je možno, da se ne odzovejo dovolj na sestavine cepiv.
Accidental intravascular administration may give rise to severe reactions or even shock. 
Nenamerno injiciranje cepiva v žilo ima lahko za posledico hude reakcije ali celo šok.
The risk of encephalitis following administration of the vaccine is far below the risk of encephalitis caused by natural diseases (measles: 1 in 1000 to 2000 cases; mumps: 2-4 in 1000 cases; rubella: approximately 1 in 6000 cases). 
Tveganje za pojav encefalitisa po cepljenju s tem cepivom je veliko manjše od tveganja za pojav encefalitisa pri naravni okužbi (ošpice: 1 na 1.000 do 2.000 primerov; mumps: 2 do 4 na 1.000 primerov, rdečke: približno 1 na 6.000 primerov).
• if you or your child has ever had a severe allergic reaction to egg protein. 
• če ste vi ali vaš otrok kdaj imeli alergijsko reakcijo na jajčne beljakovine;
The measles and mumps components of the vaccine are produced in chick embryo cell culture and may therefore contain traces of egg protein. 
Komponenti cepiva proti ošpicam in mumpsu sta pridobljeni na kulturi piščančjih embrionalnih celic in lahko zato vsebujeta jajčne proteine v sledeh.
Whether you or your child receives the vaccine will depend upon the level of your immune defenses. 
Odločitev, ali boste vi ali vaš otrok prejeli cepivo bo temeljila na nivoju vašega imunskega odziva.
PRIORIX has no or negligible influence on the ability to drive and use machines. 
Cepivo PRIORIX nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
The exception to this was pain at the injection site which was “Common” after the first vaccine dose and “Very common” after the second vaccine dose. 
Izjema je bila le bolečina na mestu injiciranja, ki je bila po cepljenju s prvim odmerkom “pogosta”, po cepljenju z drugim odmerkom pa “zelo pogosta”.
QUALITATIVE AND QUANTITATIVE COMPOSITION To be completed nationally 
KAKOVOSTNA IN KOLIČINSKA SESTAVA [izpolni država članica]
* Encephalitis has been reported with a frequency below 1 per 10 million doses. 
*Pogostnost encefalitisa je bila manjša od 1 na 10 milijonov odmerkov.
PRIORIX is contraindicated during pregnancy (see section 4.3). 
Cepivo PRIORIX je med nosečnostjo kontraindicirano (glejte poglavje 4.3).
Humoral or cellular immune deficiency (primary or acquired), including hypogammaglobulinaemia, dysgammaglobulinaemia and AIDS or symptomatic HIV infection or an age-specific CD4+ Tlymphocyte percentage in children below 12 months: CD4+ <25%; children between 12-35 months: CD4+ < 20%; children between 36-59 months: CD4+ < 15% (see section 4.4). 
Humoralna ali celična imunska pomanjkljivost (primarna ali pridobljena), vključno z hipogamaglobulinemijo, disgamaglobulinemijo in aidsom ali simptomatsko okužbo HIV, ali za starost specifični odstotek T-limfocitov CD4+ pri otrocih do 12 mesecev: CD4+ < 25 %, pri otrocih od 12 do 35 mesecev: CD4+ < 20 % oz. pri otrocih od 36 do 59 mesecev: CD4+ < 15 % (glejte poglavje 4.4).
WITH 2 SEPARATE NEEDLES: PACK OF 1, 10, 25, 100 WITHOUT NEEDLE: PACK OF 1, 10, 20, 25, 40, 100 
Z 2 LOČENIMA IGLAMA: PAKIRANJE PO 1, 10, 25, 100 BREZ IGLE: PAKIRANJE PO 1, 10, 20, 25, 40, 100
Other medicines and Priorix 
Druga zdravila in cepivo Priorix
The safety profile presented below is based on a total of approximately 12,000 subjects administered PRIORIX in clinical trials. 
V nadaljevanju predstavljen profil varnosti temelji na podatkih približno 12.000 oseb, ki so cepivo PRIORIX prejele v kliničnih preskušanjih.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before you are given this vaccine. 
Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte s svojim zdravnikom ali s farmacevtom, preden boste cepljeni s tem cepivom.
PRIORIX has not been evaluated in fertility studies. 
Cepiva PRIORIX niso ocenili v študijah plodnosti.
Pregnancy (see section 4.6). 
Nosečnost (glejte poglavje 4.6)
In case of high fever following vaccination please consult your doctor promptly; 
V primeru zvišane telesne temperature po cepljenju se nemudoma posvetujte s svojim zdravnikom;
General disorders and administration site conditions: Kawasaki syndrome 
Splošne težave in spremembe na mestu aplikacije: Kawasakijev sindrom
• abnormal crying 
• neobičajen jok;
• fever of 38°C or higher 
• zvišana telesna temperatura 38 °C ali višja).
A known contact dermatitis (skin rash when the skin is in direct contact with allergens such as neomycin) should not be a problem but talk to your doctor first; 
Znani kontaktni dermatitis (pojav kožnega izpuščaja po neposrednem stiku kože z alergeni, kot je neomicin) ne bi smel biti težava, vendar se pred cepljenjem kljub temu najprej posvetujte s svojim zdravnikom;
Therefore a second dose of PRIORIX should be given within three months to provide optimal immune responses. 
Zato je treba za zagotovitev optimalnega imunskega odziva drugi odmerek cepiva PRIORIX dati v treh mesecih.
• if you or your child has a weakened immune defenses (e.g. because of an HIV infection. 
• če imate vi ali vaš otrok oslabljeno imunsko obrambo (npr. zaradi okužbe s HIV).
Note: This SmPC, labelling and packages leaflet is the version valid at the time of Commission decision. 
Opomba: Ta povzetek glavnih značilnosti zdravila, označevanje in navodilo za uporabo so različice, veljavne ob izdaji Odločbe komisije.
• fever higher than 39.5°C 
• zvišana telesna temperatura (višja od 39,5 °C);
• if you or your child is known to be allergic to neomycin (an antibiotic agent). 
• če ste vi ali vaš otrok alergični na neomicin (antibiotik).
Due to minor variation of its pH, the reconstituted vaccine may vary in colour from clear peach to fuchsia pink without deterioration of the vaccine potency. 
Zaradi manjših odstopanj pH-ja lahko barva rekonstituiranega cepiva variira od svetle breskove do fuksijsko rožnate, kar ne zmanjša učinkovitosti cepiva.
The safety and efficacy of PRIORIX in infants under 9 months of age has not been established. 
Varnost in učinkovitost cepiva PRIORIX pri dojenčkih, mlajših od 9 mesecev nista bili dokazani.
• if you or your child has any illness or takes any medicine that weakens the immune system such as Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS). 
• če imate vi ali vaš otrok katerokoli bolezen ali jemljete zdravilo, ki oslabi imunski sistem, npr. virus imunske pomanjkljivosti (HIV) ali sindrom pridobljene imunske pomanjkljivosti (AIDS).
Women who intend to become pregnant should be advised to delay for 1 month following PRIORIX vaccination. 
Ženskam, ki nameravajo zanositi, je treba svetovati, naj to odložijo za 1 mesec po cepljenju s cepivom PRIORIX.
For use in children between 9 to 12 months of age see sections 4.2, 4.4 and 5.1. 
Za uporabo pri otrocih v starosti od 9 do 12 mesecev glejte poglavja 4.2, 4.4 in 5.1. 4.2 Odmerjanje in način uporabe
In the absence of compatibility studies, the medicinal product must not be mixed with other medicinal products. 
Zaradi pomanjkanja študij kompatibilnosti cepiva ne smemo mešati z drugimi zdravili.
• sudden life-threatening allergic reaction 
• nenadna življenje ogrožajoča alergijska reakcija;
As with all vaccines, Priorix may not fully protect all people who are vaccinated. 
Tako kot vsa cepiva tudi cepivo Priorix popolnoma ne zaščiti vseh, ki se cepijo.
The vaccine must be reconstituted by adding the entire contents of the supplied container of solvent to the vial containing the powder. 
Cepivo rekonstituirajte tako, da celotno vsebino priloženega vsebnika z vehiklom dodate v vialo s praškom.
The vaccine should be injected promptly after reconstitution. 
Cepivo morate injicirati takoj po rekonstituciji.
If a tuberculin test is to be performed, it should be done either any time before, simultaneously with, or 6 weeks after vaccination with Priorix. 
Če je potrebno opraviti tuberkulinski test, ga je potrebno izvesti pred, sočasno s cepljenjem ali šele 6 tednov po cepljenju s cepivom Priorix.
DATE OF REVISION OF THE TEXT To be completed nationally 
DATUM ZADNJE REVIZIJE BESEDILA [izpolni država članica]
Of these 147 subjects received PRIORIX and VARILRIX concomitantly. 
Med njimi jih je 147 sočasno dobilo cepivi PRIORIX in VARILRIX.
Non-clinical data reveal no special hazard for humans based on general safety studies. 
Predklinični podatki na osnovi običajnih študij varnosti ne kažejo posebnega tveganja za človeka.
Adverse reactions reported are listed according to the following frequency: Very common (1/10) 
Neželeni učinki so navedeni v skladu z naslednjo pogostnostjo: Zelo pogosti:
Individuals 12 months of age or older 
Osebe, stare 12 mesecev ali več
Persons with a history of anaphylactic, anaphylactoid, or other immediate reactions (e.g. generalised urticaria, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock) subsequent to egg ingestion may be at an enhanced risk of immediate-type hypersensitivity reactions after vaccination, although these types of reactions have been shown to be very rare. 
Pri osebah z anamnezo anafilaktičnih, anafilaktoidnih ali drugih takojšnjih reakcij (npr. generalizirana urtikarija, otekanje ustne votline in žrela, težave pri dihanju, hipotenzija ali šok) po uživanju jajc je tveganje za pojav preobčutljivostnih reakcij takojšnjega tipa po cepljenju večje, čeprav so tovrstne reakcije zelo redke.
Pregnancy must be avoided for one month after vaccination. 
Nosečnost je treba odložiti za 1 mesec po cepljenju.
These patients should be monitored carefully for signs of measles, parotitis and rubella. 
Takšne bolnike je treba natančno kontrolirati glede znakov ošpic, parotitisa in rdečk.
• Kawasaki syndrome (major signs of the illness are for instance: fever, skin rash, swollen lymph glands, inflammation and rash of the mucous membranes of the mouth and throat) 
• Kawasakijev sindrom (glavni bolezenski znaki so na primer: zvišana telesna temperatura, kožni izpuščaj, oteklina bezgavk, vnetje in izpuščaj na sluznici ust in žrela);
• bronchitis 
• bronhitis;
Read all of this leaflet carefully before you or your child receives this vaccine because it contains important information for you. 
Pred cepljenjem natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Infants in their first year of life may not respond sufficiently to the components of the vaccine, due to the possible interference with maternal antibodies (see sections 4.2 and 5.1). 
Zaradi možne prisotnosti materinih protiteles je pri dojenčkih med prvim letom življenja odziv na komponente cepiva lahko nezadosten (glejte poglavji 4.2 in 5.1).
If you have been told by your doctor that your child has an intolerance to some sugars, contact your doctor before your child receives this vaccine. 
Če vam je zdravnik povedal, da ima vaš otrok intoleranco za nekatere sladkorje, se pred cepljenjem s tem cepivom posvetujte s svojim zdravnikom.
In general, the frequency category for adverse reactions was similar for the first and second vaccine doses. 
Pogostnost neželenih učinkov je bila po cepljenju s prvim in drugim odmerkom cepiva na splošno podobna.
A clinical trial enrolled 300 healthy children 9 to 10 months of age at the time of first vaccine dose. 
Imunski odziv pri otrocih, starih od 9 do 10 mesecev Klinično preskušanje je zajelo 300 zdravih otrok, ki so bili v času prvega odmerka cepiva stari od 9 do 10 mesecev.
The seroconversion rates to the three components were comparable to those seen after subcutaneous administration. 
Deleži serokonverzije za tri sestavine so bili podobni kot po subkutani uporabi cepiva.
• if you or your child has a severe infection with a high temperature. 
• če imate vi ali vaš otrok katerokoli hujšo okužbo z zvišano telesno temperaturo.
A minor infection such as a cold should not be a problem, but talk to your doctor first; 
Blažja okužba, npr. prehlad, ne bi smela biti težava, vendar se pred cepljenjem kljub temu najprej posvetujte s svojim zdravnikom;
The injections should be given at separate injection sites. 
Cepiva je treba injicirati na različni mesti.
During post-marketing surveillance, the following adverse reactions have been reported additionally following PRIORIX vaccination. 
Med spremljanjem cepiva po pridobitvi dovoljenja za promet so dodatno poročali še o naslednjih neželenih učinkih, ki so sledili cepljenju s cepivom PRIORIX.
In clinical studies in children aged from 12 months to 2 years PRIORIX has been demonstrated to be highly immunogenic. 
Imunski odziv pri otrocih, starih 12 mesecev ali več V kliničnih študijah pri otrocih, starih od 12 mesecev do 2 leti, se je cepivo PRIORIX izkazalo za zelo imunogeno.
The presence of a minor infection, such as a cold, should not result in the deferral of vaccination. 
Blažja okužba, npr. prehlad, ne bi smela biti razlog za odložitev cepljenja.
Studies have shown that breastfeeding postpartum women vaccinated with live attenuated rubella vaccines may secrete the virus in breast milk and transmit it to breast-fed infants without evidence of any symptomatic disease. 
Študije so pokazale, da se lahko pri doječih ženskah, po porodu cepljenih z živimi oslabljenimi cepivi proti rdečkam, virus izloča v mleku in se prenaša na dojenega otroka, a ugotovili niso nobenih znakov simptomatske bolezni.
However foetal damage has not been documented when measles, mumps and rubella vaccines have been given to women who were unknowingly in early stages of pregnancy. 
Vendar pa niso ugotovili okvar plodov v primerih, ko so cepiva proti ošpicam, mumpsu in rdečkam dobile ženske, ki so bile v zgodnjem obdobju nosečnosti, ne da bi to vedele.